Weekly vs. Every-3-Week Paclitaxel for Ovarian Cancer REPLY

Journal article

Peer reviewed

John K. Chan, Mark F. Brady and Bradley J. Monk

The New England journal of medicine, Vol.374(26), pp.2603-2604

06/30/2016

PMID: 27355549

Abstract

General & Internal Medicine

Life Sciences & Biomedicine

Medicine, General & Internal

Science & Technology

2 Record Views

Title: Weekly vs. Every-3-Week Paclitaxel for Ovarian Cancer REPLY
Creators: John K. Chan - College Station Medical Center
Mark F. Brady - Roswell Pk Canc Inst, Buffalo, NY 14263 USA
Bradley J. Monk - University of Arizona
Publication Details: The New England journal of medicine, Vol.374(26), pp.2603-2604
Publisher: Massachusetts Medical Soc
Number of pages: 2
Identifiers: 991005968883402656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article